Latest Articles

Safety and efficacy of apixaban versus enoxaparin in gynecologic cancer patients undergoing open surgery: an open-label randomized controlled trial.

Oncologic safety and reproductive outcomes of conservative therapy for early-stage endometrial disease - Baishideng Publishing Group

Oncologic safety and reproductive outcomes of conservative therapy for early-stage endometrial disease Baishideng Publishing Group

Intraoperative Proctosigmoidoscopy Enhances Safety in Bowel Endometriosis Surgery: Study - Medical Dialogues

Intraoperative Proctosigmoidoscopy Enhances Safety in Bowel Endometriosis Surgery: Study Medical Dialogues

Government reassures public on safety of menstrual products following study detecting endocrine-disrupting chemicals - thestar.co.za

Government reassures public on safety of menstrual products following study detecting endocrine-disrupting chemicals thestar.co.za

Safety of sanitary products: Experts say ‘no clear evidence of harm’ - africannewsagency.com

Safety of sanitary products: Experts say ‘no clear evidence of harm’ africannewsagency.com

Why does surgery for endometriosis-associated infertility often fail to improve pregnancy outcome?

Endometriosis can impair natural reproduction through multiple mechanisms, including distortion of pelvic anatomy and chronic peritoneal inflammation. On this basis, surgical treatment might be reasonably expected to benefit. However, clinical …

Intra-ureteric indocyanine green for ureteric visualisation in complex benign gynaecological surgery: a prospective series of 50 cases.

Ureteric injury is a serious complication of gynaecological surgery, particularly in cases involving deep endometriosis. This prospective cohort study assessed the feasibility and safety of intra-ureteric indocyanine green (ICG) for …

Patient safety expert says she and her family never visit specialists alone - AusDoc

Patient safety expert says she and her family never visit specialists alone AusDoc

ACR-368 in Serous Endometrial Cancer: Strong Phase 2b Efficacy, Manageable Safety, and a Clear Accelerated Approval Path Support Buy Rating on Acrivon - TipRanks

ACR-368 in Serous Endometrial Cancer: Strong Phase 2b Efficacy, Manageable Safety, and a Clear Accelerated Approval Path Support Buy Rating on Acrivon TipRanks

ACRV: ACR-368 delivers strong efficacy and safety in serous endometrial cancer, advancing toward approval - TradingView

ACRV: ACR-368 delivers strong efficacy and safety in serous endometrial cancer, advancing toward approval TradingView